Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study.
altitude
coast-plain-hill gradient
cutaneous melanoma
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
17 May 2022
17 May 2022
Historique:
received:
13
04
2022
revised:
02
05
2022
accepted:
13
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
The incidence of cutaneous melanoma has been increasing in the last decades among the fair-skinned population. Despite its complex and multifactorial etiology, the exposure to ultraviolet radiation (UVR) is the most consistent modifiable risk factor for melanoma. Several factors influence the amount of UVR reaching the Earth's surface. Our study aimed to explore the relationship between melanoma and altitude in an area with mixed geographic morphology, such as the Veneto region (Italy). We included 2752 melanoma patients who were referred to our centers between 1998 and 2014. Demographics, histological and clinical data, and survival information were extracted from a prospectively maintained local database. Head/neck and acral melanoma were more common in patients from the hills and the mountains, while limb and trunk melanoma were more common in patients living in plain and coastal areas. Breslow thickness, ulceration and mitotic rate impaired with increased altitude. However, the geographical area of origin was not associated with overall or disease-free survival. The geographical area of origin of melanoma patients and the "coast-plain-hill gradient" could help to estimate the influence of different sun exposure and to explain the importance of vitamin D levels in skin-cancer control.
Identifiants
pubmed: 35629411
pii: life12050745
doi: 10.3390/life12050745
pmc: PMC9146073
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancer Treat Res. 2016;167:17-49
pubmed: 26601858
Biomed Pharmacother. 1990;44(10):495-501
pubmed: 2085663
Int J Cancer. 2000 Mar 1;85(5):627-32
pubmed: 10699940
PLoS One. 2015 May 13;10(5):e0126394
pubmed: 25970336
Eur J Cancer. 2021 Dec;159:98-104
pubmed: 34742161
Environ Mol Mutagen. 2018 Jun;59(5):438-460
pubmed: 29466611
Cancers (Basel). 2020 Sep 29;12(10):
pubmed: 33003444
Adv Exp Med Biol. 2008;624:104-16
pubmed: 18348451
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
ISRN Oncol. 2012;2012:864680
pubmed: 22389841
Dermatology. 2020;236(6):500-507
pubmed: 32506063
Melanoma Res. 2019 Dec;29(6):664-667
pubmed: 31469708
Cancers (Basel). 2021 Apr 03;13(7):
pubmed: 33916693
Bosn J Basic Med Sci. 2020 May 01;20(2):197-208
pubmed: 31479413
Acta Derm Venereol. 2022 Apr 08;102:adv00692
pubmed: 35312026
Int J Cancer. 2007 Mar 1;120(5):1123-8
pubmed: 17149699
Sci Rep. 2021 Mar 12;11(1):5815
pubmed: 33712642
Arch Dermatol. 2005 Apr;141(4):477-81
pubmed: 15837865
Scand J Plast Reconstr Surg. 1978;12(3):231-41
pubmed: 741212
Curr Oncol. 2022 Mar 21;29(3):2165-2173
pubmed: 35323375
Clin Exp Dermatol. 2011 Jul;36(5):544-7
pubmed: 21418285
Am J Epidemiol. 1997 Sep 1;146(5):413-7
pubmed: 9290501
Int J Dermatol. 2010 Sep;49(9):978-86
pubmed: 20883261
J Photochem Photobiol B. 2010 Nov 3;101(2):174-8
pubmed: 20430639
Actas Dermosifiliogr. 2011 Apr;102(3):199-205
pubmed: 21334587